Tian Liu

11 Xizhimen South Street
Xizhimen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Identification of distinct subgroups in Chinese patients with Behçet's syndrome via cluster analysis of immune cells and clinical features.

Identification of distinct subgroups in Chinese patients with Behçet's syndrome via cluster analysis of immune cells and clinical features.

Journal: Arthritis research & therapy

Published: April 15, 2026

Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial.

Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial.

Journal: Arthritis research & therapy

Published: November 27, 2025

Elevated Peripheral CD161+ Treg Cells and Their Clinical Significance in Behçet Syndrome.

Elevated Peripheral CD161+ Treg Cells and Their Clinical Significance in Behçet Syndrome.

Journal: ACR open rheumatology

Published: October 29, 2025

Efficacy and safety of mufemilast in patients with Behçet's syndrome: a phase 2 randomised clinical trial.

Efficacy and safety of mufemilast in patients with Behçet's syndrome: a phase 2 randomised clinical trial.

Journal: Annals of the rheumatic diseases

Published: October 20, 2025

Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis: A Randomized Clinical Trial.

Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis: A Randomized Clinical Trial.

Journal: JAMA network open

Published: May 19, 2025

Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a multicentre, single-arm trial.

Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a multicentre, single-arm trial.

Journal: Rheumatology (Oxford, England)

Published: March 04, 2025

Efficacy and safety of low-dose interleukin 2 for Behçet's syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trial.

Efficacy and safety of low-dose interleukin 2 for Behçet's syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trial.

Journal: Nature communications

Published: November 11, 2024

Assessment of common carotid artery wall stiffness using shear wave elastography: a promising technique for evaluating active and inactive Behçet's disease.

Assessment of common carotid artery wall stiffness using shear wave elastography: a promising technique for evaluating active and inactive Behçet's disease.

Journal: Quantitative imaging in medicine and surgery

Published: July 17, 2024

Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study.

Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study.

Journal: Clinical and experimental medicine

Published: May 28, 2024

Deficiency of peripheral CLA+ Tregs and clinical relevance in Behcet's syndrome.

Deficiency of peripheral CLA+ Tregs and clinical relevance in Behcet's syndrome.

Journal: Arthritis research & therapy

Published: January 18, 2024

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial.

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial.

Journal: JAMA network open

Published: November 10, 2022

Refractory Behçet's disease treated with low-dose interleukin-2: A case report.

Refractory Behçet's disease treated with low-dose interleukin-2: A case report.

Journal: Medicine

Published: October 25, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026